Source: Health Products Regulatory Authority (IE) Revision Year: 2020 Publisher: HCS bvba, H.Kennisstraat 53, Edegem 2650, Belgium
Dasergin 5 mg film-coated tablets.
Pharmaceutical Form |
---|
Film-coated tablet (tablet) Light blue, round, film-coated tablets with beveled edges (diameter: 6.5 mm, thickness: 2.3–3.5 mm). |
Each film-coated tablet contains 5 mg desloratadine.
Excipient with known effect: Each film-coated tablet contains 16.15 mg lactose (as monohydrate) and 0.201 mg (0.00875 mmol) sodium.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Desloratadine |
Desloratadine is a non-sedating, long-acting histamine antagonist with selective peripheral H1-receptor antagonist activity. After oral administration, desloratadine selectively blocks peripheral histamine Η1-receptors because the substance is excluded from entry to the central nervous system. |
List of Excipients |
---|
Tablet core: Microcrystalline cellulose Film coating: Hypromellose |
Blister (OPA/Alu/PVC//Alu): 10, 30 or 100 film-coated tablets, in a box.
Not all pack sizes may be marketed.
HCS bvba, H.Kennisstraat 53, Edegem 2650, Belgium
PA2096/006/001
Date of first authorisation: 6th July 2018
Drug | Countries | |
---|---|---|
DASERGIN | Estonia, Ireland, Poland, Romania |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.